VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,376 | -65.9% | 147,073 | -10.6% | 0.01% | -64.7% |
Q2 2023 | $4,033 | -1.6% | 164,483 | -6.6% | 0.02% | -5.6% |
Q1 2023 | $4,099 | +48.5% | 176,196 | +61.5% | 0.02% | +28.6% |
Q4 2022 | $2,760 | -99.9% | 109,093 | -45.3% | 0.01% | -33.3% |
Q3 2022 | $3,843,000 | +5.3% | 199,417 | +39.2% | 0.02% | +10.5% |
Q2 2022 | $3,648,000 | +1751.8% | 143,249 | +1756.0% | 0.02% | +1800.0% |
Q1 2022 | $197,000 | -1.5% | 7,718 | +65.8% | 0.00% | 0.0% |
Q3 2021 | $200,000 | – | 4,655 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |